Paper415661
Sensitive bioassay for vancomycin.
Walker CA and 1 other. Antimicrob Agents Chemother, 1978. Cited by 50 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Sensitive bioassay for vancomycin. Papers, record 415661. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/415661
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Vancomycin | Major topic |
| Adult | |
| Biological Assay | |
| Body Fluids | |
| Female | |
| Humans | |
| Immunodiffusion |
Source PubMed
References2
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 13,928,813 | Ototoxicity of neomycin and other antibiotics. | J Laryngol Otol | 1962 | https://conductscience.org/library/papers/13928813 | PubMed |
| 2 | 5,142,052 | Prevention of staphylococcal shunt infections by continuous vancomycin prophylaxis. | Am J Med Sci | 1971 | https://conductscience.org/library/papers/5142052 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39,766,523 | Therapeutic Monitoring of Vancomycin Implemented by Eremomycin ELISA. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/39766523 | PubMed |
| 36,364,147 | An Overview of Analytical Methodologies for Determination of Vancomycin in Human Plasma. | Molecules | 2022 | https://conductscience.org/library/papers/36364147 | PubMed |
| 31,713,055 | Does oral vancomycin use necessitate therapeutic drug monitoring? | Infection | 2020 | https://conductscience.org/library/papers/31713055 | PubMed |
| 22,848,719 | Synergy between vancomycin and nafcillin against Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model. | PLoS One | 2012 | https://conductscience.org/library/papers/22848719 | PubMed |
| 9,306,605 | Oral vancomycin hydrochloride therapy for postoperative methicillin-cephem-resistant Staphylococcus aureus enteritis. | Surg Today | 1997 | https://conductscience.org/library/papers/9306605 | PubMed |
| 7,325,638 | Comparison of vancomycin disposition in rats with normal and abnormal renal functions. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/7325638 | PubMed |
| 7,247,352 | Sensitive radioimmunoassay for vancomycin. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/7247352 | PubMed |
| 6,772,095 | Bioassay for determination of vancomycin in the presence of rifampin or aminoglycosides. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6772095 | PubMed |
| 6,703,678 | Concentrations of vancomycin in bone and serum of normal rabbits and those with osteomyelitis. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6703678 | PubMed |
| 6,436,291 | Comparison of fluorescence polarization immunoassay and bioassay of vancomycin. | J Clin Microbiol | 1984 | https://conductscience.org/library/papers/6436291 | PubMed |
| 6,386,852 | Laboratory evaluation of five assay methods for vancomycin: bioassay, high-pressure liquid chromatography, fluorescence polarization immunoassay, radioimmunoassay, and fluorescence immunoassay. | J Clin Microbiol | 1984 | https://conductscience.org/library/papers/6386852 | PubMed |
| 6,357,070 | Evaluation of an automated fluorescence polarization immunoassay for vancomycin. | Antimicrob Agents Chemother | 1983 | https://conductscience.org/library/papers/6357070 | PubMed |
| 3,530,582 | Clinical pharmacokinetics of vancomycin. | Clin Pharmacokinet | 1986 | https://conductscience.org/library/papers/3530582 | PubMed |
| 2,952,062 | Clinical evaluation of efficacy, pharmacokinetics, and safety of teicoplanin for serious gram-positive infections. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/2952062 | PubMed |
| 2,354,591 | Clearance from dialysate and equilibration of intraperitoneal vancomycin in continuous ambulatory peritoneal dialysis. | Clin Pharmacokinet | 1990 | https://conductscience.org/library/papers/2354591 | PubMed |
| 2,149,492 | Application of a modified bioassay for monitoring serum teicoplanin and vancomycin in febrile neutropenic patients. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2149492 | PubMed |
| 718,158 | Safety of oral vancomycin in functionally anephric patients. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/718158 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/415661
GET https://conductscience.org/api/papers/v1/415661/authors